Evidence map›Paper›PMID 24442708›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2014

The phenotypic spectrum of DYT24 due to ANO3 mutations.

Maria Stamelou, Gavin Charlesworth, Carla Cordivari, Susanne A Schneider, Georg Kägi, Una-Marie Sheerin, Ignacio Rubio-Agusti, Amit Batla, Henry Houlden, Nicholas W Wood and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Tremor pathophysiology.Clinical parkinsonism & related disorders · 2026
    Review
  5. Rare Movement Disorders-An Approach for Clinicians.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Hereditary Truncal Dystonia Associated with ANO3 Gene Variant.Movement disorders clinical practice · 2025
    Article
  8. Article
  9. TMEM16 proteins: CaInternational journal of molecular medicine · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. The role of laboratory investigations in the classification of tremors.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  14. Review
  15. Polymodal Control of TMEM16x Channels and Scramblases.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Tremor in Primary Monogenic Dystonia.Current neurology and neuroscience reports · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Maria StamelouSobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, United Kingdom; Neurology Clinic, Attiko Hospital, University of Athens, Greece.
Gavin Charlesworth
Carla Cordivari
Susanne A Schneider
Georg Kägi
Una-Marie Sheerin
Ignacio Rubio-Agusti
Amit Batla
Henry Houlden
Nicholas W Wood
Kailash P Bhatia
University College London · GBZero to Three · USKantonsspital St. Gallen · CHKiel University · DENational Hospital for Neurology and Neurosurgery · GB

Funding

Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council G1100479Medical Research Council MC_G1000735Medical Research Council MR/J004758/1Parkinson's UK G-1107Wellcome Trust 089698
6 · The paper itself

Abstract

Genes causing primary dystonia are rare. Recently, pathogenic mutations in the anoctamin 3 gene (ANO3) have been identified to cause autosomal dominant craniocervical dystonia and have been assigned to the dystonia locus dystonia-24 (DYT24). Here, we expand on the phenotypic spectrum of DYT24 and provide demonstrative videos. Moreover, tremor recordings were performed, and back-averaged electroencephalography, sensory evoked potentials, and C-reflex studies were carried out in two individuals who carried two different mutations in ANO3. Ten patients from three families are described. The age at onset ranged from early childhood to the forties. Cervical dystonia was the most common site of onset followed by laryngeal dystonia. The characteristic feature in all affected individuals was the presence of tremor, which contrasts DYT24 from the typical DYT6 phenotype. Tremor was the sole initial manifestation in some individuals with ANO3 mutations, leading to misdiagnosis as essential tremor. Electrophysiology in two patients with two different mutations showed co-contraction of antagonist muscles, confirming dystonia, and a 6-Hz arm tremor at rest, which increased in amplitude during action. In one of the studied patients, clinically superimposed myoclonus was observed. The duration of the myoclonus was in the range of 250 msec at about 3 Hz, which is more consistent with subcortical myoclonus. In summary, ANO3 causes a varied phenotype of young-onset or adult-onset craniocervical dystonia with tremor and/or myoclonic jerks. Patients with familial cervical dystonia who also have myoclonus-dystonia as well as patients with prominent tremor and mild dystonia should be tested for ANO3 mutations.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAge of OnsetAnoctaminsChloride ChannelsDystonic DisordersFemaleHumansMaleMiddle AgedMutationMyoclonusPhenotypeANO3 protein, humanAnoctaminsChloride ChannelsANO3cervical dystoniacranial dystoniadystonic tremorDYT24laryngeal dystonia

Identifiers

PMID24442708
PMCPMC4150528
OpenAlexW2139112710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.